Iovera
Payments companies reported to CMS as associated with Iovera. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Iovera, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Iovera
These are the largest totals companies reported as associated with Iovera. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Varacallo | Du Bois, PA | Family Medicine | $411,131.53 |
| Karina Gritsenko | Bronx, NY | Anesthesiology | $381,439.69 |
| Vinod Dasa | Kenner, LA | Orthopaedic Surgery | $338,647.49 |
| Gary Schwartz | Brooklyn, NY | Pain Medicine (Anesthesiology) | $291,795.11 |
| Nirav Amin | Placentia, CA | Orthopaedic Surgery | $204,769.86 |
| Jacob Hutchins | Minneapolis, MN | Anesthesiology | $195,688.99 |
| Clay Guynn | Lexington, KY | Physical Medicine & Rehabilitation | $184,815.10 |
| William Rogenmoser | Alexandria, LA | Physical Medicine & Rehabilitation | $178,167.56 |
| Mark Kronenfeld | Brooklyn, NY | Anesthesiology | $176,013.00 |
| Pieter Vreede | Rushville, IN | Anesthesiology | $135,321.98 |
Prescribed Iovera?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.